Startup · $50m raised
Every investor coverage indicates participated in a round QBiotics raised.
| Investor | Rounds | Invested |
|---|---|---|
| TDM Growth Partners | Unnamed stage | - |
Companies QBiotics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
| Name | Role | Sources |
|---|---|---|
| Dr Victoria Gordon | Founder | Cut Through Venture, SmartCompany |
Stories naming QBiotics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Health technology governance veteran Sergio Duchini joins ANDHealth's board, adding capital markets and R&D commercialisation expertise to the digital health accelerator.
Cut Through Venture's newsletter reviews first-half 2021 Australian and New Zealand startup funding, covering aggregate round statistics, new unicorns, founder age patterns, and the strong funding of recently founded COVID-era companies.
Cut Through Venture's debut quarterly newsletter rounds up Q1 2021 raises across Australian and New Zealand startups, highlighting crowdfunding, fintech dominance, active investors, and two newly launched startups currently seeking backers.
Weekly roundup reporting QBiotics' $50 million raise, LAB Group's $4 million from Costa Asset Management, Hudled's $640,000 backing, and Stripe's US$600 million round at a US$95 billion valuation.
Also Cut Through Venture